The Japanese immunologist Tasuku Honjo contributed to the discovery of mechanisms and proteins critical to the regulation of immune responses, which led to the development of novel immunotherapies against cancer, namely the development of anti-programmed cell death protein 1 (PD-1) cancer immunotherapies. The gene discussed is PDCD1; the disease is cancer.